The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100
Updated: 02-01-2024
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2026
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 01-05-2025
AUST R: 161298
Expected supply: 04 Jul 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Stallergenes Australia Pty Ltd, can be contacted for details on supply on 1800 824 166.
Updated: 10-06-2025
AUST R: 18695
Expected supply: 31 Jul 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 14-05-2025
AUST R: 32486
Expected supply: 31 Mar 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 10-07-2025
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 15 Sep 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 24-06-2025
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2026
Availability: Unavailable
Updated: 31-10-2023
adrenaline (epinephrine) acid tartrate
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Expected supply: Unknown
Availability: Unavailable
Management action: Products are available in another presentation.
Updated: 14-08-2024
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 Aug 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 23-05-2025
AUST R: 81930
Expected supply: 29 Aug 2025
Availability: Unavailable
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 29-05-2025
AUST R: 81931
Expected supply: 29 Aug 2025
Availability: Unavailable
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 29-05-2025
AUST R: 144970
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 19-12-2024
AMIKACIN WOCKHARDT amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
AUST R: 288798
Expected supply: 30 Apr 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 30-06-2025
AUST R: 94175
Expected supply: 28 Feb 2025
Availability: Unavailable
Management action: This product is being replaced by ZARONTIN ethosuximide 250mg capsule bottle (ARTG 461005). An unregistered product has been approved for supply under Section 19A. The approval holder, Clinect Pty Ltd, can be contacted for details on supply on 1800 899 005.
Updated: 08-01-2025
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 30-06-2025
AUST R: 18845
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. The approval holder, Link Medical Products Pty Ltd, can be contacted for details on supply on 1800 181 060.
Updated: 04-04-2025
ISOPRENALINE MACURE isoprenaline hydrochloride 1 mg/5 mL solution for injection ampoule
AUST R: 370377
Expected supply: 31 Dec 2025
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 23-06-2025
cefepime hydrochloride monohydrate
CEFEPIME KABI cefepime (as hydrochloride) 1 g powder for injection vial
AUST R: 227966
Expected supply: Unknown
Availability: Unavailable
Management action: An alternative generic product is available.
Updated: 30-10-2024
cefepime hydrochloride monohydrate
CEFEPIME KABI cefepime (as hydrochloride) 2 g powder for injection vial
AUST R: 227965
Expected supply: Unknown
Availability: Unavailable
Management action: An alternative generic product is available.
Updated: 30-10-2024
AUST R: 61885
Expected supply: Unknown
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 09-05-2024
noradrenaline (norepinephrine) acid tartrate monohydrate
Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial
AUST R: 183622
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available.
Updated: 16-09-2024
HEPARINISED SALINE 50IU/5mL (porcine mucous) injection ampoule
AUST R: 66684
Expected supply: 30 Apr 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 13-02-2025
AUST R: 15417
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Product will be replaced by METHOBLASTIN methotrexate (as sodium) 10 mg tablet blister pack ARTG 410933.
Updated: 18-06-2024
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
AUST R: 170446
Expected supply: 30 Sep 2027
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 01-05-2025
AUST R: 337517
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic product is available.
Updated: 12-07-2024
AUST R: 337512
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic product is available.
Updated: 12-07-2024
magnesium chloride hexahydrate
EXTRANEAL 7.5% w/v icodextrin peritoneal dialysis solution bag AHB5546
AUST R: 91344
Expected supply: 30 Sep 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. The approval holder, Vantive Pty Ltd, can be contacted for details on supply on 1800 920 133.
Updated: 11-07-2025
adrenaline (epinephrine) acid tartrate
AUST R: 210672
Expected supply: 22 May 2025
Availability: Available
Updated: 22-05-2025
PEGASYS peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe
AUST R: 91836
Expected supply: 30 Sep 2025
Availability: Limited Availability
Management action: This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient.
An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328.
The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection
Updated: 10-07-2025
PEGASYS peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe
AUST R: 91837
Expected supply: 30 Sep 2025
Availability: Unavailable
Management action: This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient.
An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328.
The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection
Updated: 10-07-2025
EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe
AUST R: 375490
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other generic by same sponsor available – EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe with safety lock system (ARTG 429090)
Updated: 23-08-2024
EXARANE FORTE enoxaparin sodium 120mg/0.8mL solution for injection prefilled syringe
AUST R: 375492
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other generic by same sponsor available – EXARANE FORTE enoxaparin sodium 120mg/0.8mL solution for injection prefilled syringe with safety lock system (ARTG 429092)
Updated: 23-08-2024
magnesium chloride hexahydrate
DIANEAL PD-4 Low Calcium with 2.5% w/v Glucose Peritoneal Dialysis Solution bag
AUST R: 16847
Expected supply: 31 Jul 2025
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 08-10-2024
magnesium chloride hexahydrate
DIANEAL PD-4 Low Calcium with 1.5% w/v Glucose Peritoneal Dialysis Solution bag
AUST R: 16750
Expected supply: 31 Jul 2025
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 08-10-2024
NEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampoule
AUST R: 219054
Expected supply: 27 Jun 2025
Availability: Available
Updated: 27-06-2025
AUST R: 14328
Expected supply: 31 Jul 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Global Medical Solutions, can be contacted for details on supply on 02 9503 8100.
Updated: 26-06-2025
AUST R: 46942
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available.
Updated: 13-09-2024
DBL ACETYLCYSTEINE injection concentrate acetylcysteine 2 g/ 10 mL injection ampoule
AUST R: 121503
Expected supply: 17 Apr 2025
Availability: Available
Updated: 22-04-2025
adrenaline (epinephrine) acid tartrate
ADRENALINE-LINK 1:1,000 1mg/1mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 12048
Expected supply: 17 Jun 2025
Availability: Available
Updated: 18-06-2025
Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial
AUST R: 12723
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: The product will be replaced by: PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial ARTG 399600
Updated: 15-10-2024
EXARANE enoxaparin sodium 20mg/0.2mL solution for injection prefilled syringe
AUST R: 375494
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other generic by same sponsor available – EXARANE enoxaparin sodium 20mg/0.2mL solution for injection prefilled syringe with safety lock system (ARTG 429094)
Updated: 16-10-2024
DBL HEPARIN SODIUM 5000IU/1mL (porcine mucous) injection BP ampoule
AUST R: 12881
Expected supply: 12 May 2025
Availability: Available
Updated: 12-05-2025
AUST R: 14667
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 07-02-2025
3% CITANEST DENTAL WITH OCTAPRESSIN 2.2mL injection cartridge
AUST R: 220320
Expected supply: 30 Apr 2025
Availability: Available
Updated: 30-04-2025
APRESOLINE hydralazine hydrochloride 20mg powder for injection ampoule
AUST R: 43190
Expected supply: 31 Mar 2026
Availability: Available
Management action: An unregistered product has been approved for supply under Section 19A commencing on 1 August 2025. The approval holder, Boucher & Muir Pty Ltd T/A Advanz Pharma, can be contacted for details on supply on 1800 627 680.
Updated: 10-06-2025
naloxone hydrochloride dihydrate
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
AUST R: 309381
Expected supply: 05 May 2025
Availability: Available
Updated: 05-05-2025
AUST R: 59743
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their health professional to discuss alternative treatment options
Updated: 24-12-2024
GENTAMICIN NORIDEM gentamicin (as sulfate) 80 mg/2 mL solution for injection ampoule
AUST R: 391250
Expected supply: 15 Apr 2025
Availability: Available
Updated: 22-04-2025
AUST R: 16263
Expected supply: 04 Jun 2025
Availability: Available
Updated: 04-06-2025
AMIODARONE JUNO amiodarone hydrochloride 150mg/3mL solution for injection ampoule
AUST R: 233673
Expected supply: 30 Apr 2025
Availability: Available
Updated: 05-05-2025
AUST R: 337516
Expected supply: 30 Jan 2026
Availability: Available
Management action: Other strengths are available.
Updated: 30-05-2025
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial
AUST R: 303807
Expected supply: 25 Jun 2025
Availability: Available
Updated: 10-07-2025
ACETYLCYSTEINE-LINK INJECTION acetylcysteine 2g/10mL concentrated injection ampoule
AUST R: 170803
Expected supply: 04 Aug 2025
Availability: Unavailable
Management action: An alternative brand is available. An unregistered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 18-06-2025
XELABINE capecitabine 500 mg film-coated tablet blister pack
AUST R: 213045
Expected supply: 22 Jul 2025
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. Please contact the approval holder Pro Pharmaceuticals Group on 1300 077 674.
Updated: 28-05-2025
CRESEMBA isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack
AUST R: 305452
Expected supply: 16 May 2025
Availability: Available
Updated: 16-05-2025
noradrenaline (norepinephrine) acid tartrate monohydrate
AUST R: 232701
Expected supply: 01 Apr 2025
Availability: Available
Updated: 14-04-2025
AUST R: 233443
Expected supply: 30 Jan 2026
Availability: Unavailable
Management action: Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 27-06-2025
MIACALCIC calcitonin salmon (salcatonin) 100IU/1mL injection ampoule
AUST R: 13363
Expected supply: 25 Aug 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 27-06-2025
Updated: 24-06-2025
DBL SULFAMETHOXAZOLE 400 mg and TRIMETHOPRIM 80 mg/5 mL concentrated injection ampoule
AUST R: 16293
Expected supply: 30 Sep 2025
Availability: Limited Availability
Management action: An alternative brand is available.
Updated: 02-07-2025
benzathine benzylpenicillin tetrahydrate
AUST R: 147169
Expected supply: 30 Sep 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 04-07-2025
AUST R: 74895
Expected supply: 12 Sep 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 30-05-2025
AUST R: 79745
Expected supply: 15 Nov 2025
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 23-05-2025
noradrenaline (norepinephrine) acid tartrate monohydrate
AUST R: 248512
Expected supply: 08 May 2025
Availability: Available
Updated: 08-05-2025
NATULAN procarbazine 50mg (as hydrochloride) capsule blister pack
AUST R: 231199
Expected supply: 14 May 2025
Availability: Available
Updated: 14-05-2025
ZAVICEFTA 2000/500 ceftazidime (as pentahydrate) and avibactam (as sodium) powder for injection vial
AUST R: 301205
Expected supply: 29 Aug 2025
Availability: Available
Management action: Sponsor is working to expedite the next shipment and is closely controlling the supply.
Updated: 02-07-2025
CORDARONE X INTRAVENOUS amiodarone hydrochloride 150mg/3mL injection ampoule
AUST R: 15360
Expected supply: 08 Jul 2025
Availability: Available
Updated: 08-07-2025
PRIORIX ALBUMIN FREE VACCINE 0.5mL powder for injection vial and diluent syringe
AUST R: 97842
Expected supply: 30 Sep 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. This shortage is applicable to the private market for this product. There is no impact on the government or NIP supply.
Updated: 23-06-2025
AUST R: 170002
Expected supply: 05 Jun 2025
Availability: Available
Updated: 06-06-2025
DBL BLEOMYCIN 15000IU (as sulfate) powder for injection vial
AUST R: 42569
Expected supply: 31 Mar 2026
Availability: Available
Management action: Sponsor is closely controlling the supply. Supply of an alternative product is under consideration
Updated: 15-05-2025
suxamethonium chloride dihydrate
SUXAMETHONIUM JUNO suxamethonium chloride dihydrate 100 mg/2 mL injection ampoule
AUST R: 320687
Expected supply: 01 Jun 2025
Availability: Available
Updated: 02-06-2025
MEDSURGE MUPIROCIN NASAL OINTMENT mupirocin (as calcium) 20 mg/g (2% w/w) ointment tube
AUST R: 300228
Expected supply: 15 Jul 2025
Availability: Available
Management action: An alternative generic product is available. Sponsor is closely controlling the supply.
Updated: 23-06-2025
AUST R: 82503
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available
Updated: 15-05-2025
AUST R: 159342
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Reduction in supply until supply is exhausted
Updated: 16-05-2025
AUST R: 159338
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Reduction in supply until supply is exhausted
Updated: 16-05-2025
AUST R: 115008
Expected supply: 01 Jan 2026
Availability: Limited Availability
Management action: Sponsor is closely controlling the supply.
Updated: 30-06-2025
ORAQIX Periodontal Gel lidocaine (lignocaine) 25 mg/g, prilocaine 25 mg/g
AUST R: 143855
Expected supply: 31 Jul 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 17-06-2025
AUST R: 18770
Expected supply: 04 Jul 2025
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment.
Updated: 16-06-2025
PRIORIX-TETRA vaccine 0.5mL powder for injection vial with diluent syringe
AUST R: 107286
Expected supply: 15 Jul 2025
Availability: Unavailable
Management action: This shortage is only applicable to the private market. There is no impact on the government or NIP supply.
Updated: 02-07-2025
AUST R: 461005
Expected supply: 30 Jul 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Clinect Pty Ltd, can be contacted for details on supply on 1800 899 005.
Updated: 10-06-2025
phenoxymethylpenicillin potassium
ASPECILLIN VK phenoxymethylpenicillin 500mg (as potassium) tablet bottle
AUST R: 200137
Expected supply: 31 Aug 2025
Availability: Available
Management action: The sponsor is closely controlling the supply. An alternative presentation is available.
Updated: 12-06-2025
AUST R: 48231
Expected supply: 30 Sep 2025
Availability: Available
Management action: The sponsor is closely controlling the supply. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 27-06-2025
AUST R: 233442
Expected supply: 30 Dec 2025
Availability: Available
Management action: Sponsor is closely controlling the supply
Updated: 24-06-2025
AUST R: 39954
Expected supply: 25 Jul 2025
Availability: Limited Availability
Management action: Sponsor is working to expedite the next shipment.
Updated: 04-07-2025
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 5mg tablet bottle
AUST R: 120271
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 10mg tablet bottle
AUST R: 120272
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 15mg tablet bottle
AUST R: 120273
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
Updated: 27-06-2025
Equine antithymocyte immunoglobulin
ATGAM equine antithymocyte immunoglobulin 250mg/5mL injection ampoule
AUST R: 12282
Expected supply: 31 Oct 2025
Availability: Available
Management action: The sponsor is closely controlling supply
Updated: 26-06-2025
DOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack
AUST R: 375471
Expected supply: 05 Sep 2025
Availability: Available
Management action: Sponsor is closely controlling supply and working to expedite the next shipment.
Updated: 07-07-2025
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/